Boston, Massachusetts--(Newsfile Corp. - August 16, 2021) - Block & Leviton is investigating Sesen Bio, Inc. (NASDAQ: SESN) for potential securities law violations. Investors who have lost money in their Sesen Bio investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://www.blockleviton.com/cases/sesn.
What is this all about?
During trading hours on August 13, 2021, Sesen Bio announced that the U.S. Food and Drug Administration (FDA) declined to approve the Company's Biologics License Application (BLA) for its bladder cancer treatment Vicineum. Shares of Sesen Bio stock had traded up over 50% since the market opened on August 9, 2021 after the Company announced second quarter 2021 earnings.
On this news shares of Sesen Bio stock fell 75% in intraday trading.
Who is eligible?
Anyone who purchased Sesen Bio stock and has lost money as a result of this news may be eligible, whether or not they have sold their investment. Investors should contact Block & Leviton to learn more.
What is Block & Leviton doing?
Block & Leviton is investigating whether the Company committed securities law violations and may file an action to attempt to recover losses on behalf of investors who have lost money.
What should you do next?
If you've lost money on your investment, you should contact Block & Leviton to learn more via our case website, by email at cases@blockleviton.com, or by phone at (617) 398-5600.
Why should you contact Block & Leviton?
Many law firms have issued releases about this matter; most of those firms do not actually litigate securities class actions. Block & Leviton is a law firm that actually litigates cases. We are dedicated to obtaining significant recoveries on behalf of defrauded investors through active litigation in the federal courts across the country. Many of the nation's top institutional investors hire us to represent their interests. You can learn more about us at our website, www.blockleviton.com, or call (617) 398-5600 or email cases@blockleviton.com with any questions.
This notice may constitute attorney advertising.
CONTACT:
BLOCK & LEVITON LLP
260 Franklin St., Suite 1860
Boston, MA 02110
Phone: (617) 398-5600
Email: cases@blockleviton.com
SOURCE: Block & Leviton LLP
www.blockleviton.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/93234.
